The Claim
Patients with coronary artery disease exhibit significantly greater epicardial adipose tissue thickness compared to patients with valvular heart disease without coronary disease, and this increased thickness is associated with lower adiponectin levels and higher leptin and interleukin-6 levels within the epicardial adipose tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with coronary artery disease have thicker fat tissue around the heart than those with valvular heart disease but no coronary disease. This thicker fat tissue contains lower levels of adiponectin and higher levels of leptin and interleukin-6.
See the scientific wording
Patients with coronary artery disease have significantly greater epicardial adipose tissue thickness than patients with valvular heart disease without coronary disease, and this thickness is associated with reduced adiponectin and increased leptin and interleukin-6 in the same tissue.
When blood flow to the heart muscle is reduced, the fat layer around the heart becomes starved of oxygen. This causes fat cells to stop making a protective molecule and start producing more inflammatory molecules. These inflammatory molecules spread to nearby blood vessels, causing damage and worsening plaque buildup.
What the research says
1 studyPeople with coronary artery disease have more inflamed fat around their hearts that makes less protective molecules and more inflammatory ones than people with heart valve problems. This study found exactly that.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.